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Aim: Mycobacteria other than tuberculosis (MOTT) cause increasingly serious infections especially in
immunosuppressive patients by direct transmission from the environment or after colonization. However,
identification of these species is difficult because of the cost and difficulties in defining to species level.
Identification and distribution of these species can help clinician in the choice of treatment.
Materials and methods: A total of 90 MOTT strains obtained from four different centers were included in the
study. These strains were identified by sequence analysis of 16S rRNA and Hsp65 genetic regions.
Results: Accordingly, within the 90 MOTT strains, 17 different species were identified. In order of frequency, these
species were M. gordonea (n = 21), M. abscessus (n = 13), M. lentiflavum (n = 9), M. fortuitum (n = 8), M. intracellulare
(n = 6), M. kumamotonense (n = 6), M. neoaurum (n = 5), M. chimaera (n = 5), M. alvei (n = 5), M. peregrinum (n = 3),
M. canariasense (n = 3), M. flavescens (n = 1), M. mucogenicum (n = 1), M. chelona (n = 1), M. elephantis (n = 1), M.
terrae (n = 1) and M. xenopi (n = 1). Most frequently identified MOTT species according to the geographical origin
were as follows: M. abscessus was the most common species either in Istanbul or Malatya regions (n = 6, n = 6,
consequently). While M. kumamotonense was the most frequent species isolated from Ankara region (n = 6),
M. gordonea was the most common for Samsun region (n = 14).
Conclusion: Our study revealed that frequency of MOTT varies depending on the number of clinical samples and
that frequency of these species were affected by the newly identified species as a result of the use of novel
molecular methods. In conclusion, when establishing diagnosis and treatment methods, it is important to know
that infections caused by unidentified MOTT species may vary according to the regions in Turkey. The results of the
study showed that there were differences in the frequency of MOTT species in the different geographical regions
of Turkey.
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Genus Mycobacterium causes an ever-increasing number
of serious infections especially in immunosuppressive
patients via colonization and environmental contamina-
tion [1]. Some mycobacteria are potentially pathogenic
for people. Especially in recent years, increased inci-
dence of Acquired Immunodeficiency Syndrome (AIDS)
and widespread use of chemotherapeutic drugs for inter-
ventional therapies and cancer treatment have further* Correspondence: murat@omu.edu.tr
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stated.increased the prevalence and importance of Mycobac-
teria other than tuberculosis (MOTT) infections [2,3].
These bacteria, commonly found in the environment,
may cause various infections [1]. Studies have shown
that MOTT colonize in respiratory tracts of hospitalized
and dialysis patients and cause local abscess and nosoco-
mial outbreaks especially in patients receiving injection
or intravenous treatment [2,3]. Since the equipments
used in hospitals (endoscopes, devices in dialysis units,
etc.) may contain infectious bacteria, they may cause
various infections in patients receiving interventional
treatment. Despite the measures taken, one may expe-
rience difficulties in controlling and protecting someral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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which may cause serious infections including affecting
various systems in immunosuppressive patients are diffi-
cult to treat. Antibiotic treatment of M. abscessus infec-
tion, one of the rapidly growing MOTT species, is often
unsuccessful and the risk of death increases in patients
who have not undergone surgery [2,4]. Therefore, detec-
tion and identification of Mycobacterium species and de-
termining of their antibiotic sensitivity are necessary for
the control of infections caused by MOTT species and
for the determination of epidemiology and treatment
regimens. But clinical and laboratory diagnosis of infec-
tions is relatively difficult and expensive [4-6]. Therefore,
in the cases in which identification is not possible, con-
sidering the results of the MOTT species distribution
may help clinicians in the selection of empirical therapy
[3,5,6]. For this purpose, we aimed to identify various
MOTT species isolated from four different centers in
our country at species-level and to establish the most
frequently isolated MOTT species.
Materials and methods
Ninety strains isolated from clinical specimens and iden-
tified as MOTT at the same center between 2001 and
2008 were used in the study. Of the strains, 40 were
identified in Samsun Ondokuz Mayis University (OMU)
Medical Faculty, Mycobacteriology Reference Labora-
tory, 19 in Ankara Refik Saydam Hygiene Center, Myco-
bacteriology Reference Laboratory, 20 in Malatya Inonu
University, Medical Faculty, Mycobacteriology Reference
Laboratory and 11 in Istanbul University, Istanbul Me-
dical Faculty, Mycobacteriology Reference Laboratory.
Strains were initially typed via classical methods. Then,
sequencing of the 16S rRNA and Hsp65 gene regions
were assessed. Sequencing results were compared with
the sequences of mycobacteria in GenBank and those
displaying compatibility over 98% were accepted as
species [7].
Results
DNA sequence analysis of both gene regions of the 90
strains with respect to their frequencies were defined as
follows: M. gordonae (21), M. abscessus (13), M. lenti-
flavum (9), M. fortuitum (8), M. intracellulare (6),
M. kumamotonense (6), M. neoaurum (5), M. chimaera
(5), M. alvei (5), M. peregrinum (3) and M. canariasense
(3) and M. flavescense (1), M. mucogenicum (1), M. che-
lona (1), M. elephantis (1), M. terrae (1), M. xenopi (1).
Considering the four strains from four centers,
frequency order of the strains with respect to region was
as follows: Of the strains obtained at OMU Medical
Faculty, Mycobacteriology Laboratory (n = 40), the most
frequently detected species were M. gordonae (14 strains),
M. fortuitum (8 strains), M. neoaurum (5 strains),M. lentiflavum (4 strains), M. alvei (4 strains), S. intracel-
lulare (1 strain), M. peregrinum (1 strain), M. flavescense
(1 strain), M. elephantis (1 strain), M. chelona (1 strain);
Of the strains obtained at Inonu University, Turgut Özal
Medical Center, Mycobacteriology Laboratory (n = 20),
the most frequently detected species were M. abscessus
(6 strains), M. chimaera (4 strains), M. gordonae
(2 strains), M. canariasense (2 strains), M. lentiflavum
(2 strains), M. intracellulare (two strains), M. peregrinum
(1 strain) M. mucogenicum (1 strain); Of the strains ob-
tained at Istanbul University Medical Faculty, Mycobacter-
iology Laboratory (n = 11), the most frequently detected
species were M. abscessus (6 strains) M. lentiflavum
(2 strains), M. canariasense (2 strains), M. chimaera
(1 strain) and of the strains obtained at Ankara Refik Say-
dam Hygiene Center Mycobacteria Laboratory (n = 19),
the most frequently detected species were M. kumamoto-
nense (6 strains), M. gordonae (4 strains), M. intracellulare
(3 strains), M. abscessus (1 strain), M. lentiflavum
(1 strain), M. alvei (1 strain), M. peregrinum (1 strain),
M. terrae (1 strain), M. xenopi (1 strain) (Table 1). Accord-
ing to regions the distribution of MOTT species shown on
the map (Figure 1).
Discussion
Atypical mycobacteria so-called MOTT may colonize
and cause serious diseases especially in immunosup-
pressive patients as well as hospitalized and healthy
people. Nontuberculous Mycobacterial factors consti-
tute 0.5-35% of all mycobacterial infections in humans
[8,9]. In patients with underlying disease such as AIDS,
this rate approaches 50% [6]. Several studies have revealed
that infections caused by these factors have become more
important in recent years [4-6]. Studies also revealed that
the number of hospital infections caused by MOTT have
increased due to the reasons such as inadequate disinfec-
tion and sterilization. Progressive increases in the number
of infections caused by MOTT, which are commonly
found in our environment, make rapid and reliable identi-
fication of these species more important [3,4,10]. As the
diagnosis and treatment of MOTT infections are mostly
species-dependent and these strains are resistant to
conventional anti-tuberculosis drugs, typing of Myco-
bacterium that requires different treatment protocols
is necessary. However, typing of these species is not
possible in every center [2,5,8]. Conventional methods
used in typing of Mycobacteria are difficult to imple-
ment and molecular methods which are more sensitive
and specific require more expensive materials. Their use is
limited with difficulties encountered in standardization
and requirement of specially trained personnel. This
leads failures and delays in diagnosis and treatment
[5,11,12]. Treatment of infections belonging to MOTT
species which can not be identified due to insufficient
Table 1 Distribution of MOTT strains with respect to centers they obtained
Typing result Malatya Istanbul Samsun Ankara
n:90 n:20 n:11 n:40 n:19
(100%) (22,3%) (12,2%) (44,4%) (21,1%)
M. gordonae n:21 (23,3%) 2 1 14 (35%)* 4
M. abscessus n:13 (14,4%) 6 (30%)* 6 (54,5%)* - 1
M. lentiflavum n:9 (10%) 2 2 4 1
M. fortuitum n:8 (8,8%) - - 8 -
M. intracellulare n:6 (6,6%) 2 - 1 3
M. kumamotonense n:6 (6,6%) - - - 6 (31,6%)*
M. neoaurum n:5 (5,5%) - - 5 -
M. alvei n:5 (5,5%) - - 4 1
M. chimaera n:5 (5,5%) 4 1 - -
M. peregrinum n:3 (3,3%) 1 - 1 1
M. canariasense n:3 (3,3%) 2 1 - -
M. flavescens n:1 (1,1%) - - 1 -
M. mucogenicum n:1 (1,1%) 1 - - -
M. terrae n:1 (1,1%) - - - 1
M. xenopi n:1 (1,1%) - - - 1
M. elephantis n:1 (1,1%) - - 1 -
M. chelonae n:1 (1,1%) - - 1 -
n: Number of strains.
*The most commonly identified strains according to the provinces they obtained.
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incidence of that region. Knowing frequency of nontuber-
culous mycobacterium species in our country will provide
guidance on empirical treatments. But studies on this
issue are limited in Turkey. In their study, Bedir et al.
identified 11M. gordonae from 17 MOTT species
which were isolated from clinical specimens in AnkaraFigure 1 Distribution of nontuberculous mycobacteria strains in Turkprovince [9]. In their study conducted in Hacettepe Uni-
versity Hospital, Engin et al. found that M. gordonae (n =
11) was the most common one among 22 MOTT species
isolated from clinical specimens [13]. Again, in their study
conducted in Mersin University, Bayram et al. identified
all MOTT species (n = 7) isolated from clinical specimens
as M. fortuitum [14]. Çavuşoğlu et al. (2001) isolated 19ey.
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gordonae was the most frequent one (57.9%) [15]. In their
study conducted in Ege University, Çavuşoğlu et al. (2005)
found that M. fortuitum, M. peregrinum and M. intra-
cellulare were the most frequent ones among 29 MOTT
species [16]. Uzun et al. identified 11 MOTT species and
found that M. fortuitum was the most common species
[17]. Bicmen et al. isolated 77 MOTT species and found
that M. gordonae was the most frequently encountered
species [18]. The incidence of MOTT infections is re-
ported to increase with a rate of 8-9% each year [19].
While infections belonging to Mycobacterium avium com-
plex (MAC), M. xenopi and M. malmoense species are
prominent in Scandinavian countries and England, MAC
species and M. kansasii infections in the United States
and M. malmoense infections in Canada are the common
cause of infections [2,6,20]. In Africa, M. fortuitum is the
most frequent MOTT species isolated from the patients
[6,19]. Studies regarding the incidence of MOTT in the
world are numerous. Gruben-Jaworska et al. studied 4192
patients between 1999 and 2005 and identified 303 nontu-
berculous mycobacteria (NTM) [21]. According to the re-
port of the Beijing Research Institute for Tuberculosis
Control, of the 52 MOTT species 48.1% were identified as
MAC and followed by M. gordonae [19]. In a comprehen-
sive study conducted in Taiwan, M. abscessus and M.
avium were found to be the most frequent species among
MOTT which were isolated from patients and followed by
other rapidly growing species [22]. In their study con-
ducted in China, Hong-Xiu et al. found that M. chelonae
was the most common species followed by M. fortuitum
among 248 MOTT from clinical specimens [19]. Bold
et al. suggested that slowly-growing species are usually
isolated from lower respiratory tract whereas rapidly gro-
wing species are more frequently isolated from other tis-
sues [23]. While MAC is the most frequently isolated
MOTT species in West Asia, rapidly growing MOTT spe-
cies are more frequent in Eastern Asia [24]. As can be
seen in the studies, M. avium, M. intracellulare, M. kan-
sasii, M. fortuitum, M. abscessus and M. chelonae are the
most frequently encountered species in clinical practice
[2,6,11,24-26]. M. fortuitum, M. cholenae/absesus and M.
smegmatis, rapidly growing mycobacteria species of
MOTT, may cause extrapulmonary disease and lead to
hospital infections in comparison with slowly-growing
species [3,6,12]. Unlike M. fortuitum, M. abscessus and M.
chelona generally appear as cause of lower respiratory
tract infection [3,6,22,24]. Although M. gordonae is the
MOTT species that is most frequently isolated from envir-
onmental factors and contamination, it is important to be
identified as a pathogen [6,27]. In a study conducted in
Hong Kong, M. gordonae was reported to be the most fre-
quent MOTT species isolated from clinical samples [26].
In a study conducted in England, incidence of MAC aswell as M. gordonae infections have been reported to in-
crease over the 10-year period [20]. Again, in a study con-
ducted in Portugal, MAC was found to be the most
frequently isolated species among 149 clinical specimens
followed by M. gordonae [28]. In our study, of the 90
MOTT species obtained from four centers, 51 (60%) were
rapidly growing MOTT species. According to the species-
level identification, the most frequently detected MOTT
species was M. gordonae, followed by M. abscessus,
whereas M. flavescense, M. mucogenicum, M. chelona, M.
elephantis, M. terrae and M. xenopi were rarely identified.
In a study involving 50 centers regarding the regional
distribution of species, MAC, M. xenopi, M. kansasii, M.
gordonae and M. fortuitum have been reported to be the
most commonly isolated species. It has also reported that
while prevalence of MAC and M. xenopi has remarkably
increased, the prevalence of M. kansasii and M. gordonae
has decreased over the years. No significant change was
observed in the isolation frequency of M. fortuitum and
M. chelonae over the years [29]. M. abscessus is the most
frequently isolated MOTT species in children [11]. It has
been reported that M. abscessus is the leading cause lower
respiratory tract infection among rapidly-growing species
[2,19]. Although it shows an alteration depending on
the region and the patient’s clinic picture, it is clear that
isolation of rapidly-growing MOTT species from clinical
samples is more common. At species-level, there are stud-
ies suggesting that M. gordonae is the most commonly
isolated species [6,8,16,26,30]. But over the years,
ever decreasing rate in the isolation of M. gordonae
in comparison to other species has been observed
[28]. This may due to the emerging measures not
allowing contamination and colonization. In our study,
M. gordonae, the mostly identified species from clinical
specimens obtained from four centers, is consistent
with the regional studies conducted in Turkey. Having
abundant M. gordonae in the environment suggest
that it may cause colonization and contamination of
clinical samples [10,11,29,31]. Having low MAC fre-
quency may be attributed to low AIDS incidence in
our country and limited clinical samples and high
M. gordonae colonization. Differences were observed in
the frequency of MOTT species with respect to the region
they obtained. While M. abscessus (6 strains) is the most
frequently detected strain obtained from Istanbul (n = 11)
and Malatya (n = 20), M. kumamotonense (6 strains) is the
most frequently detected strain obtained from Ankara
(n = 19). Of the strains obtained from Samsun (n = 40),
M. gordonae (14 strains) is the mostly identified species.
Having the result that M. gordonae is the most frequently
identified strain in Samsun is consistent with that found
in previous studies. It can be seen from the studies that in-
cidence of M. gordonae is gradually increasing and it is
frequently isolated from clinical specimens when MAC
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ignored [23,25,26]. Having MOTT species to be promin-
ent in the identification of MOTT specimens obtained
from Istanbul and Malatya is a novel knowledge for our
country. The patients’ clinical picture, types of specimens
and limited number of strains may have affected the high
incidence of M. abscessus. It has been reported that this
species is frequently isolated from tissue infections and it
has a gradually increasing incidence as a cause of lower re-
spiratory track and it frequently appears in nosocomial
factors. It must also be noted that M. gordonae may have
been a rare laboratory contaminant in these regions
[3,8,11,22,23]. At the same time, it has been suggested that
M. abscessus and analogous species have been isolated as
infection agents in children rather than the other species
[11]. However, we do not have knowledge about the pa-
tients so we could not make any comments on this issue.
M. kumamotonense, the most commonly identified species
obtained from Ankara, was identified in 2006 but M. terra
which has a genotype displaying close similarity could not
be discriminated. Therefore, as the studies on M. kuma-
motonense incidence are limited, it could have been identi-
fied in a different group [32,33]. We are of the opinion
that prominent identification of this species in a region in
Turkey is an important information.
As it can be seen in the studies, isolation frequency of
MOTT species may differ according to the geographical
region in which species were obtained as well as clinical
material, clinical manifestation and underlying disease of
the patient [2,4,6,19-32]. Since the treatment of lower
respiratory tract infections caused by M. abscessus is dif-
ficult in comparison to other species, it is vital to con-
sider this species in regions where this species were
isolated [2,6,8,22].
MOTT species which are common in our environment
may directly cause infections and also lead to various in-
fections after many years of infection. For those centers
which can not identify these species rapidly, knowing re-
gional distribution of MOTT may be directive for the
planning of treatment regimens. In our study, we ob-
served that rapidly growing mycobacteria are more pro-
minently isolated from samples throughout the country
but at species-level M. gordonae was the most frequently
isolated species followed by other rapidly growing species.
We also found that MOTT frequency of four different
centers may differ. Our study revealed that frequency
of MOTT varies depending on the number of clinical
samples and that frequency of these species were af-
fected by the newly identified species as a result of
the use of novel molecular methods. In conclusion,
when establishing diagnosis and treatment methods, it
is important to know that infections caused by un-
identified MOTT species may vary according to the
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